QL3 DRUG-ELUTING VERSUS BARE-METAL CORONARY STENTS: 6-MONTH CLINICAL AND ECONOMIC OUTCOMES OF A CONTROLLED STUDY FOR THE REDUCTION OF CORONARY RESTENOSIS
Brüggenjürgen BH, McBride D, Willich SN
Charité University Medical Center, Berlin, Germany

QL4 THE CONTENT VALIDITY OF CLINICIAN DERIVED PATIENT REPORTED OUTCOMES (PRO) MEASURES: THE ROLAND MORRIS DISABILITY QUESTIONNAIRE
Horowicz-Mehler N1, Evans CJ1, Abetz L2, West C3, Copley-Merriman K3, 1Mapi Values,
Boston, MA, USA; 2Mapi Values, Cheshire, UK; 3Pfizer Inc, Ann Arbor, MI, USA
 

Respiratory Diseases

RS4 PRESCRIBING PATTERNS IN AMBULATORY CARE CENTERS FOR TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Mahajan S1, Suh DC2, Valiyeva E2, Lau H3, 1Duke Clinical Research Institute, Durham, NC, USA; 2Rutgers University, Piscataway, NJ, USA; 3Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA

RS1 QUALITY OF LIFE IN ASTHMA PATIENTS IS AFFECTED BY HOME TELEMANAGEMENT
Joshi A, Amelung P, Finkelstein J, University of Maryland, Baltimore, MD, USA

RS3 ESTIMATING THE COST-EFFECTIVENESS OF FLUTICASONE PROPIONATE FOR TREATING CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Briggs A1, Wang H2, Gagnon Y2, Spencer S3, Bale G4, Spencer M5, Burge S4, 1University of
Oxford, Oxford, UK; 2Oxford Outcomes (Canada) Ltd, Vancouver, BC, Canada; 3Brunel
University, Uxbridge, UK; 4Birmingham Heartlands Hospital, Birmingham, UK; 5GlaxoSmithKline, London, UK

Moderator: Diane Simison PhD, Co-Executive Director, MEDTAP, Arlington, VA, USA
Panelists: Ruben King-Shaw MA, President, The Solutions Institute, Bethesda, MD USA
 

Issues on Use of Health Outcomes Research Information by Decision-Makers

THE PEER REVIEW PROCESS: HOW EDITORS DRAW THE LINE BETWEEN SCIENCE AND
ADVERTISING

Moderator: C. Daniel Mullins PhD, Director, Pharmaceutical Health Services Research, University of Maryland, School of Pharmacy, Baltimore, MD, USA
Panelists: Chris Carswell BSc, MSc, Editor, Pharmacoeconomics, Mairangi Bay, Auckland, New Zealand; Alan Lyles MPH, RPh, Professor, University of Baltimore, Baltimore, MD, USA;  Josephine Mauskopf PhD, VP, Health Economics, RTI Health Solutions, RTI International, Research Triangle Park, NC, USA
 

ARE WE GETTING THE MOST OUT OF ECONOMIC EVALUATION DATABASES?
 

Moderator: Michael Drummond PhD, Director, University of York, York, UK
Panelists: Peter Neumann ScD, Associate Professor of Policy and Decision Sciences, Harvard University, Boston, MA, USA; John Watkins MPH, RPh, Pharmacy Manager, Premera Blue Cross, Mountlake Terrace, WA, USA; Adrian Towse MA, Director, Office ofHealth Economics, London, UK
 

Outcomes Research (Economic, Clinical, Humanistic) Issues

KEEPING A PROMIS: THE NIH ROADMAP INITIATIVE ON PATIENT-REPORTED OUTCOMES
 

Moderator: Nancy Santanello, MD, MS, Executive Director, Epidemiology Department, Merck Research Laboratories, Blue Bell, PA, USA

Panelists: Bryce Reeve BS, MA, PhD, Psychometrician, National Institutes of Health, Bethesda, MD, USA; David Cella PhD, Professor and Director, Center on Outcomes Research and Education, Evanston Northwestern Healthcare, Evanston, IL, USA; H. Guess, University of North Carolina, Chapel Hill, Chapel Hill, NC, USA
 

10:45AM-11:15AM

Presented by Sean Sullivan PHD, 2004-2005 Past President & Chair, Nominations Committee & Professor, University of Washington, Department of Pharmacy, Seattle, WA, USA

PRESIDENT
Peter Neumann ScD, Associate Professor of Policy and Decision Sciences, Harvard School of Public Health, Boston, MA, USA

PRESIDENT-ELECT
Michael Drummond PhD, Director, University of York, Centre for Health Economics, Heslington, York, UK

PAST PRESIDENT
Lieven Annemans PhD, MSc, Mman, Professor & Senior Consultant, Ghent University, HEDM and IMS Health, Meise, Belgium

DIRECTOR (2004-2006)
Laurie Burke MPH, RPh, Director, Study Endpoints and Label Development, Office of New Drugs, CDER, FDA, Rockville, MD, USA

DIRECTOR (2004-2006)
Jens Grueger PhD, Head of Pricing and Health Economics Department, Novartis Pharmaceuticals AG, Basel, Switzerland

DIRECTOR (2004-2006)
Isao Kamae MD, DrPH, Professor of Biostatistics and Health Decision Sciences, Graduate School of Medicine, Kobe University, Kobe, Japan

DIRECTOR (2005-2007)
Joyce Cramer, Associate Research Scientist, Yale University School of Medicine, West Haven, CT

DIRECTOR (2005-2007)
Scott Ramsey MD, PhD, Associate Member, Fred Hutchinson Cancer Research Center, Seattle, WA, USA

TREASURER (2004-2007)
Lorne Basskin PharmD, Clinical Coordinator, Pharmacy Services, North Shore Medical Center, Miami, FL, USA

EXECUTIVE DIRECTOR
Marilyn Dix Smith RPh, PhD, Executive Director, ISPOR, 3100 Princeton Pike, Lawrenceville, NJ, USA
 

12:30PM–1:30PM

LUNCH, EXHIBITS & CONTRIBUTED POSTER PRESENTATIONS VIEWING - SESSION I I GRAND OPENING
& ISPOR 10 YEARS CELEBRATION

 
VALUE-BASED REIMBURSEMENT SIG OPEN MEETING   Delaware A

Speaker: Diane L. Simison PhD, Executive Director, MEDTAP Center for Pricing & Reimbursement  

The mission, working groups, leadership and future activities of the SIG will be presented.  

Open to all meeting participants.  

ISPOR QUALITY OF LIFE SIG OPEN MEETING  Delaware B

Speaker: Judith Barr PhD, Associate Professsor, Northeastern University & Director, National Education and Research Center for Outcomes Assessment, Boston, MA

The mission, working groups, leadership and future activities of the SIG will be presented.  

Open to all meeting participants.

ISPOR RETROSPECTIVE DATABASE SIG OPEN MEETING   Maryland AB

Speakers: Carl Asche, PhD, Co-Chair Classification of Databases Working Group & Associate Professor, University of Utah, Salt Lake City, Utah; Gordon Cummins MS, Co-Chair Classification of Databases Working Group & Vice President, Sales & Account Management, HealthCore, Inc.

This Open Meeting is a continuation of the RETROSPECTIVE DATABASE SIG FORUM to provide an opportunity for attendees to comment on how to find these database organizations and the right questions to ask for information about the types of databases (questionnaire form).

Open to all meeting participants.
 

5:00PM-7:00PM